Talis Biomedical Corp Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Talis Biomedical Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Talis Biomedical Corp for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Option Exercise | C | 0.00 | 128,655 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Option Exercise | C | 0.00 | 131,642 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Option Exercise | C | 0.00 | 300,000 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Option Exercise | C | 0.00 | 31,519 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Buy | C | 0.00 | 89,968 | 0 | 182,025 | 92.1 K to 182 K (+97.73 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Buy | C | 0.00 | 92,057 | 0 | 92,057 | 0 to 92.1 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Buy | P | 16.00 | 5,300 | 84,800 | 215,090 | 209.8 K to 215.1 K (+2.53 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Buy | C | 0.00 | 209,790 | 0 | 209,790 | 0 to 209.8 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Popovits Kimberly J | Director | Buy | C | 0.00 | 22,041 | 0 | 25,776 | 3.7 K to 25.8 K (+590.12 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 432,749 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 478,402 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Option Exercise | C | 0.00 | 1,076,643 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | C | 0.00 | 302,621 | 0 | 1,390,064 | 1.1 M to 1.4 M (+27.83 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | C | 0.00 | 334,546 | 0 | 1,087,443 | 752.9 K to 1.1 M (+44.43 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Scott Randal W. | Director | Buy | C | 0.00 | 752,897 | 0 | 752,897 | 0 to 752.9 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 6,427,576 | 0 | 27,511,741 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 536,438 | 0 | 2,345,481 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 7,286,794 | 0 | 21,084,165 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 536,414 | 0 | 1,809,043 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 1,941 | 0 | 5,420 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 6,654,603 | 0 | 13,797,371 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 598,860 | 0 | 1,272,629 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 7,142,768 | 0 | 7,142,768 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 673,769 | 0 | 673,769 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 3,479 | 0 | 3,479 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 9,191,433 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 767,106 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 10,420,117 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 767,072 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 2,776 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 9,516,082 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 856,370 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 10,214,159 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 963,490 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.00 | 4,975 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 9,191,433 | 0 | 9,191,433 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 767,106 | 0 | 767,106 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 16.00 | 5,792,538 | 92,680,608 | 7,003,176 | 1.2 M to 7 M (+478.47 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 16.00 | 457,462 | 7,319,392 | 571,659 | 114.2 K to 571.7 K (+400.59 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Ramakrishnan Ramesh | Sr. Vice President, ... | Buy | P | 16.00 | 1,000 | 16,000 | 1,000 | 0 to 1,000 |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Posard Matthew L. | Director | Buy | P | 16.00 | 62,500 | 1,000,000 | 62,500 | 0 to 62.5 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Moody John Roger Jr | Chief Financial Off ... | Buy | P | 16.00 | 1,700 | 27,200 | 1,700 | 0 to 1.7 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Liu Douglas | Sr. Vice President, ... | Buy | P | 16.00 | 4,000 | 64,000 | 4,000 | 0 to 4 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Flick Karen E. | Chief of Staff, Sr. ... | Buy | P | 16.00 | 2,000 | 32,000 | 2,000 | 0 to 2 K |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Option Exercise | C | 0.00 | 10,630 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Option Exercise | C | 0.00 | 12,035 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Option Exercise | C | 0.00 | 21,568 | 0 | 0 | |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Buy | C | 0.00 | 7,433 | 0 | 33,486 | 26.1 K to 33.5 K (+28.53 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Buy | C | 0.00 | 8,416 | 0 | 26,053 | 17.6 K to 26.1 K (+47.72 %) |
| Feb 19 2021 | TLIS | Talis Biomedical C ... | Coe Brian | Chief Executive Off ... | Buy | C | 0.00 | 15,082 | 0 | 17,637 | 2.6 K to 17.6 K (+590.29 %) |